Guwahati Mail

Wearable Injectors Market Expected to Reach $23.89 Billion by 2031, Growing at 15.29% CAGR

 Breaking News
  • No posts were found

Wearable Injectors Market Expected to Reach $23.89 Billion by 2031, Growing at 15.29% CAGR

October 26
02:37 2024
Wearable Injectors Market Expected to Reach $23.89 Billion by 2031, Growing at 15.29% CAGR
Wearable Injectors Market
Wearable Injectors Enhance Patient Safety and Reduce Healthcare Costs by Enabling At-Home Administration, Minimizing Hospital Visits and Needle Stick Injuries.

Wearable Injectors Market size was valued at USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031). Wearable injectables are delivery structures that adhere to the skin, permitting long-term application of drugs to the skin. The mechanical capabilities of a wearable injector offer unique dosing and transport accuracy, among different medical benefits. The additives of every wearable injection are same, a tube for passing the veins, an area to attach the needle to the skin, and a device that provides the perfect dosage. Comparing wearable injectors to traditional injecting techniques, they are a more affordable form of administration. The wearable injectors market is anticipated to grow owing to the advantages of these devices over conventional injections, including higher dosage levels while properly monitored.

Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/wearable-injectors-market

Competitive Environment in the Wearable Injectors Market: An Enlarged View

The wearable injectors market has witnessed a dynamic and competitive environment driven by the rapid adoption of advanced drug delivery systems and growing demand for patient-friendly medical devices. Leading companies such as Medtronic, BD (Becton, Dickinson & Company), Insulate Corporation, Amgen, and Ypsomed are dominating the industry, driving the technological advances and expanding their services to cater to a diverse therapeutic area.

BD is strengthening its presence in the market with innovations in automated devices and expanding the utility of its wearable injectors beyond diabetes, oncology and autoimmune diseases. Their purchasing strategy has also enabled them to have increased their influence in the biological sciences. Insulate Corporation is another key company with its Omnipod® system, a waterless insulin delivery system. Insulet distinguished itself by the simplicity and user-friendliness of the device design, with a focus on improving the user experience.

Strategic Cooperation and Partnership

In January 2022, Insulet’s Omnipod 5 delivery device for insulin delivery was granted U.S. patents. With this certification, the company hopes to release the first wearable tubeless automated insulin administration device that blends the Omnipod 5 with Dexcom’s G6 continuous glucose monitoring system.

In April 2021, Five Prime Therapeutics, a clinical biotechnology company specializing in the development of immuno-oncology and targeted cancer drugs, was officially acquired by Amgen. Amgen believes that by acquiring Five Prime for gastric cancer, it can take advantage of Bemarituzumab, a first-line treatment, to help gastric cancer patients.

For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/wearable-injectors-market

This report covers the following segments:

A. Type

On-Body

Off-Body

B.  Therapy 

Diabetes

Cardiovascular disease

Immuno-oncology

Others

This report covers the following players:

Ypsomed

Amgen

Subcuject (Denmark)

Becton, Dickinson and Company (BD)

Bespak Europe Ltd.

CeQur SA

Debiotech SA

Enable Injections

Insulet Corporation

Medtronic plc

Mylan N.V.

Nemera Development S.A.

Omron Corporation

Pfizer Inc.

Roche Holding AG

Sensile Medical AG

SteadyMed Therapeutics, Inc.

Tandem Diabetes Care, Inc.

United Therapeutics Corporation

West Pharmaceutical Services, Inc.

Zosano Pharma Corporation

Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/wearable-injectors-market

Growing Shift Toward Convenient Drug Delivery

The future of wearable injectors holds strong potential, and it offers a simple, patient-centered solution for drug delivery systems. The wearable injectors market is poised for tremendous growth owing to increasing demand for personalized medicines, advancements in the biopharmaceuticals, and increasing incidence of chronic diseases. These devices provide patients find an easier, pain-free way to manage chronic conditions, reducing health care burden. As technological innovations continue, such as smaller, more user-friendly designs, this market is expected to expand rapidly in the coming years.

To read the full report, please visit: https://www.skyquestt.com/report/wearable-injectors-market

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/wearable-injectors-market